[mewzilla]

They've seen it in animal studies...

Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022

Holy crap, maybe even with convalescent plasma...

The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development

[2aProtectsTheRest]

First link references the 2012 study done in SARS2003.

That study focused on antibodies to the N (nucleocapsid) protein. None of the vaccines target that antigen and none produce antibodies to it. Know what does produce antibodies to the N protein? Infection.

Second link again talks about evidence from SARS2003 studies, along with RSV and Dengue vaccine research.

STILL no evidence anywhere of any ADE in vaccinated or reinfected COVID-19 patients.

Do you read your links before you post them?